Response-guided multidrug therapy for hepatitis C can cut treatment time in half. PDF Print
NEJM: Conclusions In this study, among patients with chronic HCV infection who had not received treatment previously, a regimen of peginterferon–ribavirin for 24 weeks, with telaprevir for the first 12 weeks, was noninferior to the same regimen for 48 weeks in patients with undetectable HCV RNA at weeks 4 and 12, with an extended rapid virologic response achieved in nearly two thirds of patients.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.